EpiPen prices aren't the only thing to jump at Mylan. Executive salaries have also seen a stratospheric uptick.The story goes on to note that during the same period, Mylan increased their
Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch's total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase, according to data provided by Connecture.
That's what you're paying for in drug prices: Greedhead executives raising their own pay from "stratospheric" to "unconscionable" and spreading money in D.C. to get more corporate welfare.
Isn't capitalism wonderful?